Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ALN-PCS
Also known as: siRNA against hypercholesterolemia
print preview
bookmark
share with colleague
General Information
Company
Alnylam Pharmaceuticals Inc.
Description
Small interfering RNA (siRNA) against proprotein convertase subtilisn/kexin type 9 (PCSK9) gene
Molecular Target
Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of Action
Gene silencing
Latest Stage of Development
Phase I
Indication
Hypercholesterolemia
Partner
The Medicines Co.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy